Objective:
Reflect on the author’s ASCP presidency, organizational priorities, and upcoming transition at the next Annual Meeting.
Approach:
- Presidential year: The author describes the 2025 Annual Meeting in Atlanta, the CEO search, and the Board’s selection of interim CEO Ali Brown as ASCP’s full-time CEO.
- Challenges and priorities: The article notes concerns about reimbursement cuts, confidence in standard medical practices, the affordability of new technologies, and recruitment of future practitioners.
- Organizational work: The author discusses collaboration with other professional societies, development of a new strategic plan, and plans for a Governance Committee to replace the Bylaws Committee.
Key Findings:
- Ali Brown was elected ASCP’s full-time CEO and is the first woman to hold the position.
- ASCP leaders have begun work on a new strategic plan and a Governance Committee.
- The next meeting in Montréal will be ASCP’s first international meeting, held in partnership with the Canadian Association for Pathologists (CAP-ACP).
Interpretation:
The author expresses optimism about ASCP’s future, citing collaboration across professional societies, the strategic-planning process, and the Society’s financial and professional resources.
Limitations:
- This is a first-person presidential reflection, not a research study; it provides no methods or quantitative outcome data.
Conclusion:
The author’s term ends at the Montréal meeting, while ASCP’s work to improve pathology and laboratory medicine practice continues.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

About the Author(s)
Gregory G. Davis
President of the American Society for Clinical Pathology